Learn more
Log in
0 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Industries
Headquarters
Stage
Employees
Links
8 members
3 members
1 members
2 members
Singularity University
6 followers
Product School
5 followers
Minerva University
4 followers
ExamRoom.AI
3 followers
Xeris Pharmaceuticals
2 followers
Discover companies